KYMR vs ONC
Kymera Therapeutics, Inc. · BeOne Medicines AG
Relative return (rebased to 100)
Key stats
| Metric | KYMR | ONC |
|---|---|---|
| Price | $118.15 | $366.73 |
| Market Cap | $9.72B | $530.02B |
| P/E | — | 1847.19 |
| P/B | 6.31 | 111.34 |
| P/S | 247.86 | 99.20 |
| ROE | -20.2% | 6.0% |
| Net Margin | -794.0% | 5.4% |
| Gross Margin | — | 87.5% |
| Revenue Growth | -16.7% | 40.2% |
| Dividend Yield | — | — |
| EPS | -$3.79 | $0.20 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.